Two Day PV (Pharmacovigilance) Audit Strategy Planning Workshop: A Practical Approach to Design and Implementation - Burlingame, CA, United States - May 11-12, 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation" conference to their offering.

The European Medicines Agency's (EMA) Guideline on good pharmacovigilance practices (GVP), Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements and to determine its effectiveness. It includes audit of the pharmacovigilance system which is covered by the quality system. The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis.

The legally required risk based audit strategy shall cover all PV processes and tasks undertaken by or delegated to other departments, MAH affiliates, and third parties such as distributors, external service providers, partners (the PV Universe). The PV Audit Strategy Plan is used to prepare the PV audit program, i.e. annual PV Audit Schedule.

In this two day workshop conference we will review the EMA and FDA requirements regarding Risk Based Audits of the PV system and Quality System. The course will focus on the design of the PV audit strategy, identification of the PV processes and entities subject to PV audit (define the PV audit universe), development of risk assessment methodology, development of procedures/tools to monitor PV processes and activities, and implementation of the PV audit strategy plan. Additionally, we will review methods of quality oversight and management of third parties performing PV activities.

Learning Objectives:

- Develop a high-level PV audit strategy

- Identify the PV activities and processes subject to PV audit

- Develop risk assessment criteria

- Identify the PV audit universe - entities subject to PV audit

- Categorize the entities subject to PV audit

- Perform risk assessments

- Prioritize entities for audit according to relative risk

- Prepare a 3-5 year PV audit plan

- Identify procedures/tools to monitor PV quality of third parties

Who Should Attend:

- PV Quality Assurance Staff

- PV Compliance professionals

- Quality auditors

- Pharmacovigilance Auditors

- Relevant Pharmacovigilance Staff

- PV Service Provider Relationship Managers

- MAH Affiliates responsible for Pharmacovigilance

For more information about this conference visit http://www.researchandmarkets.com/research/768xhg/pv

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Discovery, Photovoltaics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Discovery, Photovoltaics